TNF and rheumatoid arthritis: In patients with an active form of RA, SA, or CD, the impact of treatment with TNF antagonists on circulating T lymphocytes was evaluated by analyzing ex vivo their proliferation and their rapid release of interferon (IFN)-γ in response to mycobacterial antigens.